These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11788979)

  • 61. Tools of the trade: a comparative analysis of approaches to priority setting in healthcare.
    Mitton C; Donaldson C
    Health Serv Manage Res; 2003 May; 16(2):96-105. PubMed ID: 12803949
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Variation in average costs among federally sponsored state-organized cancer detection programs: economies of scale?
    Mansley EC; Duñet DO; May DS; Chattopadhyay SK; McKenna MT
    Med Decis Making; 2002; 22(5 Suppl):S67-79. PubMed ID: 12369233
    [TBL] [Abstract][Full Text] [Related]  

  • 63. QALYs, standard gambles, and the expected budget constraint.
    Blomqvist A
    J Health Econ; 2002 Mar; 21(2):181-95. PubMed ID: 11939237
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-effectiveness acceptability curves--caveats quantified.
    Jakubczyk M; Kamiński B
    Health Econ; 2010 Aug; 19(8):955-63. PubMed ID: 19688780
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
    Dolan P; Edlin R
    J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Determinants of Change in the Cost-effectiveness Threshold.
    Paulden M; O'Mahony J; McCabe C
    Med Decis Making; 2017 Feb; 37(2):264-276. PubMed ID: 27553208
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The concept of cost in the economic evaluation of health care. A theoretical inquiry.
    Johannesson M
    Int J Technol Assess Health Care; 1994; 10(4):675-82. PubMed ID: 7843887
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Health care cost control: a short-term problem.
    White J
    Appl Health Econ Health Policy; 2002; 1(1):9-10. PubMed ID: 14618742
    [No Abstract]   [Full Text] [Related]  

  • 70. Is the societal perspective in cost-effectiveness analysis useful for decision makers?
    Russell LB; Fryback DG; Sonnenberg FA
    Jt Comm J Qual Improv; 1999 Sep; 25(9):447-54. PubMed ID: 10481813
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Making cost assessments based on RCTs more useful to decision-makers.
    Baltussen R; Ament A; Leidl R
    Health Policy; 1996 Sep; 37(3):163-83. PubMed ID: 10160021
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stochastic league tables: an application to diabetes interventions in the Netherlands.
    Hutubessy RC; Niessen LW; Dijkstra RF; Casparie TF; Rutten FF
    Health Econ; 2005 May; 14(5):445-55. PubMed ID: 15386648
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A guide to economic evaluation: methods for cost-effectiveness analysis of person-level data.
    Hoch JS; Smith MW
    J Trauma Stress; 2006 Dec; 19(6):787-97. PubMed ID: 17195977
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The usefulness of average cost-effective ratios.
    Laska EM; Meisner M; Siegel C
    Health Econ; 1997; 6(5):497-504. PubMed ID: 9353650
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers.
    Teutsch SM; Murray JF
    Am J Manag Care; 1999 Mar; 5(3):301-5. PubMed ID: 10351026
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discounting in the economic evaluation of health care interventions.
    Krahn M; Gafni A
    Med Care; 1993 May; 31(5):403-18. PubMed ID: 8501989
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Statistical determination of cost-effectiveness frontier based on net health benefits.
    Laska EM; Meisner M; Siegel C; Wanderling J
    Health Econ; 2002 Apr; 11(3):249-64. PubMed ID: 11921321
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The interpretation of results of economic evaluation: explicating the value of health.
    Ament A; Baltussen R
    Health Econ; 1997; 6(6):625-35. PubMed ID: 9466144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.